BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23683424)

  • 1. [p15(INK4B) methylation on prognosis and response to decitabine in patients with MDS].
    Zhang Y; Song LX; Wu LY; Chang CK; Li X
    Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):237-41. PubMed ID: 23683424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment.
    Daskalakis M; Nguyen TT; Nguyen C; Guldberg P; Köhler G; Wijermans P; Jones PA; Lübbert M
    Blood; 2002 Oct; 100(8):2957-64. PubMed ID: 12351408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of the p15(INK4B) gene in acute leukemia and myelodysplastic syndromes.
    Chen H; Wu S
    Chin Med J (Engl); 2002 Jul; 115(7):987-90. PubMed ID: 12150726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation.
    Tien HF; Tang JH; Tsay W; Liu MC; Lee FY; Wang CH; Chen YC; Shen MC
    Br J Haematol; 2001 Jan; 112(1):148-54. PubMed ID: 11167795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of HO-1 promoted apoptosis induced by decitabine via increasing p15INK4B promoter demethylation in myelodysplastic syndrome.
    Ma D; Fang Q; Wang P; Gao R; Sun J; Li Y; Hu XY; Wang JS
    Gene Ther; 2015 Apr; 22(4):287-96. PubMed ID: 25652099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression.
    Quesnel B; Guillerm G; Vereecque R; Wattel E; Preudhomme C; Bauters F; Vanrumbeke M; Fenaux P
    Blood; 1998 Apr; 91(8):2985-90. PubMed ID: 9531610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.
    Song LX; Xu L; Li X; Chang CK; Zhang Y; Wu LY; He Q; Zhang QX; Li X
    Ann Hematol; 2012 Dec; 91(12):1879-86. PubMed ID: 22895556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome.
    Grövdal M; Khan R; Aggerholm A; Antunovic P; Astermark J; Bernell P; Engström LM; Kjeldsen L; Linder O; Nilsson L; Olsson A; Wallvik J; Tangen JM; Oberg G; Jacobsen SE; Hokland P; Porwit A; Hellström-Lindberg E
    Clin Cancer Res; 2007 Dec; 13(23):7107-12. PubMed ID: 18056190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of p15(INK4B) Methylation in Patients With Myelodysplastic Syndromes: A Systematic Meta-Analysis.
    Ye F; Li N
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e259-e265. PubMed ID: 31023595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of heme oxygenase-1 in demethylating effects on SKM-1 cells induced by decitabine.
    Gao R; Ma D; Wang P; Sun J; Wang JS; Fang Q
    Genet Mol Res; 2015 Dec; 14(4):17788-98. PubMed ID: 26782424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abnormality of p15(INK4b) gene and myelodysplastic syndrome].
    Wang Z; Li YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):362-5. PubMed ID: 12513775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs].
    Ye XS; Liu T; Cui X; Meng WT; Xi YM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):57-9. PubMed ID: 17294728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic alterations of p15(INK4B) and p16(INK4A) genes in pediatric primary myelodysplastic syndrome.
    Rodrigues EF; Santos-Rebouças CB; Gonçalves Pimentel MM; Mencalha AL; Dobbin J; Da Costa ES; Fernandez Cde S; Bouzas LF; Abdelhay E; De Souza Fernandez T
    Leuk Lymphoma; 2010 Oct; 51(10):1887-94. PubMed ID: 20658957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies.
    Hackanson B; Robbel C; Wijermans P; Lübbert M
    Ann Hematol; 2005 Dec; 84 Suppl 1():32-8. PubMed ID: 16292549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome.
    Kantarjian HM; O'Brien S; Shan J; Aribi A; Garcia-Manero G; Jabbour E; Ravandi F; Cortes J; Davisson J; Issa JP
    Cancer; 2007 Jan; 109(2):265-73. PubMed ID: 17133405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
    Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of hypermethylation of DLC-1 gene in myelodysplastic syndrome patients and effects of decitabine on DLC-1 gene expression].
    Fu HY; Zhou HR; Yan JG; Chen CJ; Shen JZ
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(6):412-417. PubMed ID: 28219126
    [No Abstract]   [Full Text] [Related]  

  • 18. CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine.
    Raj K; John A; Ho A; Chronis C; Khan S; Samuel J; Pomplun S; Thomas NS; Mufti GJ
    Leukemia; 2007 Sep; 21(9):1937-44. PubMed ID: 17611569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
    Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.
    Kantarjian H; Oki Y; Garcia-Manero G; Huang X; O'Brien S; Cortes J; Faderl S; Bueso-Ramos C; Ravandi F; Estrov Z; Ferrajoli A; Wierda W; Shan J; Davis J; Giles F; Saba HI; Issa JP
    Blood; 2007 Jan; 109(1):52-7. PubMed ID: 16882708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.